Stock Track | Illumina Plunges Over 5% in Pre-Market on Disappointing Q4 Margins and Subdued Outlook

Stock Track01-15

Illumina Inc. (ILMN) saw its stock plummet over 5% in the pre-market trading session on Tuesday, following the release of the biotechnology company's mixed fourth-quarter results and subdued outlook for the year ahead.

While Illumina reported a fourth-quarter revenue of $1.1 billion, exceeding analysts' estimates of $1.072 billion, the company's profit margins for the quarter fell short of expectations. Illumina's adjusted EBIT margin for Q4 2024 stood at a mere 1.5%, significantly lower than analysts had anticipated.

Adding to investor concerns, Illumina projected an adjusted operating margin of only 23% for the full fiscal year 2025, signaling potential headwinds and profitability challenges ahead. The lackluster profit margins and subdued outlook overshadowed Illumina's topline beat, prompting a sell-off in the stock during the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment